MPCi, HSG, Temasek et al Revisit Cancer Drug Developer
11 Dec 2025
US$ 20.00
MPCi, HongShan Capital Group and Temasek Holdings (Pte) Ltd have made a follow-on investment in the US$108 m ......
Related Publications
Subscribers’ Weekly for the week ending 12 Dec 2025...
Listen to Subscribers' Weekly 12 Dec 2025...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.